Evox Therapeutics

Evox Therapeutics is an Oxford, United Kingdom based biotechnology company developing genetic medicines that expand the reach of gene therapy into the brain to transform the treatment landscape for severe neurodegenerative diseases. Its proprietary ExoEdit platform combines the natural transport capabilities of exosomes with CRISPR-based gene editing to improve the delivery, potency, and safety of genetic treatments for central nervous system disorders such as Rett Syndrome. Evox is a venture backed life-sciences company (investors include GV) and was added to the API Evangelist network as a company profile; it publishes a corporate and scientific website but does not currently expose a public developer API, SDK, or documentation surface.

Evox Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Biotechnology, Gene Therapy, and Genetic Medicine.

Evox Therapeutics’ developer surface includes engineering blog and 9 more developer resources.

🌐 Visit website 📡 Source on GitHub

11.2/100 minimal ▬ flat Agent 4/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyLife SciencesBiotechnologyGene TherapyGenetic MedicineExosomesNeurodegenerative DiseaseCRISPR

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 11.2/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.4 / 20

Commercial Clarity 2.1 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 4/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 4 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/evox-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Agent Surfaces 2

MCP servers, agent skills, and machine-readable catalogs

WellKnown

WellKnown

LLMsTxt

LLMsTxt

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Contact

Contact

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

Company 5

The organization behind the API

Website

About

Blog

Careers

LinkedIn

Source (apis.yml)

aid: evox-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/evox-therapeutics.png
name: Evox Therapeutics
description: Evox Therapeutics is an Oxford, United Kingdom based biotechnology company developing genetic medicines that
  expand the reach of gene therapy into the brain to transform the treatment landscape for severe neurodegenerative diseases.
  Its proprietary ExoEdit platform combines the natural transport capabilities of exosomes with CRISPR-based gene editing
  to improve the delivery, potency, and safety of genetic treatments for central nervous system disorders such as Rett Syndrome.
  Evox is a venture backed life-sciences company (investors include GV) and was added to the API Evangelist network as a company
  profile; it publishes a corporate and scientific website but does not currently expose a public developer API, SDK, or documentation
  surface.
url: https://raw.githubusercontent.com/api-evangelist/evox-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- gv
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Life Sciences
- Biotechnology
- Gene Therapy
- Genetic Medicine
- Exosomes
- Neurodegenerative Disease
- CRISPR
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/evox-therapeutics-domain-security.yml
- type: WellKnown
  url: well-known/evox-therapeutics-well-known.yml
- type: LLMsTxt
  url: llms/evox-therapeutics-llms.txt
- type: Website
  url: https://www.evoxtherapeutics.com
- type: About
  url: https://www.evoxtherapeutics.com/about-us/
- type: Blog
  url: https://www.evoxtherapeutics.com/news/
- type: PrivacyPolicy
  url: https://www.evoxtherapeutics.com/privacy-policy/
- type: Contact
  url: https://www.evoxtherapeutics.com/contact/
- type: Careers
  url: https://www.evoxtherapeutics.com/careers/
- type: LinkedIn
  url: https://www.linkedin.com/company/evox-therapeutics-ltd/
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence